Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Ahmad Mourad et al.|The Lancet Respiratory Medicine|2022Cited by 127
MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting α2β1 Integrin ActivationPeter Chen, William C. Parks|PLoS ONE|2009Cited by 118
miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathwaysLingyin Ge, Peter Chen|JCI Insight|2016Cited by 49
Integrative genomic identification of therapeutic targets for pancreatic cancerJimmy A. Guo, Andrew J. Aguirre, Dennis Gong et al.|Cell Reports|2025Cited by 7